The Rules of the Road

Slideshow

A review of the rules of the road for doctors, because everyone remembers their first license.

I heard that you recently got your first license. Congratulations!I think everyone remembers when they first received their driver’s license. It marks a time in a teen’s life when feelings of freedom and independence (“See you later, Pops!”) compete with sheer terror (“Was I supposed to turn left there?”) for the right to dominate the psyche of the tenderfoot driver. In my hometown, shortly after we sophomores received the precious slips, some NASCAR wannabes developed an attitude of, shall we say, insouciance toward the lessons learned in driver’s education. Not surprisingly, our local police officers were delighted to itemize our various transgressions to parents, school principals, head coaches, and other unsympathetic ears.Even I, Mr. Caution himself, succumbed to the temptation to inflate my stock with the cool kids by screeching around the city streets. One night while joyriding with a car full of buddies, I hit the side of a bank-at three miles an hour, no less-a feat that requires a hitherto unknown talent for clumsiness. Thus, I was immortalized in the Gallery of Nincompoops, Vehicular Wing.Pardon? Oh, you just received your medical license. My apologies; here I am rambling on about how to start your motoring career. Wait, though-don’t leave just yet. If we think about it, medicine and driving have several principles in common. Please, take a backseat and review the rules of the road for doctors with me.Artwork by Jon Carter, Cartertoons.com 

Related Videos
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
Collaboration among nurses, social workers, and others may help in safely administering outpatient bispecific T-cell engager therapy to patients.
Immunotherapy may be an “elegant” method of managing colorectal cancer, says Gregory Charak, MD.
D. Ross Camidge, MD, PhD, spoke about how the approval of alectinib is the beginning of multiple other approvals for patients with ALK-positive NSCLC.
Nurses should be educated on cranial nerve impairment that may affect those with multiple myeloma who receive cilta-cel, says Leslie Bennett, MSN, RN.
Alexander Spira, MD, PhD, FACP, an expert on lung cancer
A panel of 4 experts on lung cancer
Treatment with cilta-cel may give patients with multiple myeloma “more time,” according to Ishmael Applewhite, BSN, RN-BC, OCN.
Nurses may need to help patients with multiple myeloma adjust to walking differently in the event of peripheral neuropathy following cilta-cel.